Skip to content

Capillarys Immunotyping 2100

by Sebia

Capillarys Immunotyping 2100 is a multiple clinical chemistry protein IVD (FDA Class I) made by Sebia, listed in FDA GUDID since 24 Jan 2018 (UDI-DI 03607360021002), registry data as of 12 Nov 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 12 Nov 2026.

Regulatory status

as of registry sync 12 Nov 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number03607360021002 UDI-DI Date24 Jan 2018ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
Device used for the detection and characterization of monoclonal proteins in human serum and urine using capillary electrophoresis
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 12 Nov 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Capillarys Immunotyping
Generic name
Multiple clinical chemistry protein IVD, reagent
Model / Ref / Catalog
2100
Primary DI / UDI-DI
03607360021002
FDA product code
CEF, DEH, DFH, CFF
GMDN term
Multiple clinical chemistry protein IVD, reagent
Device class
Class I
Regulation number
862.1630, 866.5550, 866.5510
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code CEF (Electrophoretic, Protein Fractionation).

Other devices from Sebia

See all devices from Sebia →

Properties

  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
  • Manufacturing date
Other properties (10, all answered No)